KAZIA THERAPEUTICS LTD - American Depositary Shares (KZIA) Institutional Ownership

CUSIP: 48669G105

13F Institutional Holders and Ownership History from Q4 2017 to Q1 2025

Type / Class
Equity / American Depositary Shares
Symbol
KZIA on Nasdaq
Shares outstanding
11,337,576
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 48669G105?
CUSIP 48669G105 identifies KZIA - KAZIA THERAPEUTICS LTD - American Depositary Shares in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Significant Owners of KAZIA THERAPEUTICS LTD - American Depositary Shares (KZIA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Chernett Jorey 12% +26% 1,412,662 +930% Chernett Jorey 18 Feb 2026
Alumni Capital LP 10% 0% 178,591 -77% Alumni Capital LP 31 Jul 2025
Dauntless Investment Group, LLC 0% -99% 1 -100% Dauntless Investment Group, LLC 31 Dec 2025

Institutional Holders of KAZIA THERAPEUTICS LTD - American Depositary Shares (KZIA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q1 0 $0 -$215 0
2024 Q4 0 $0 -$915,427 0
2024 Q3 2,129,596 $915,427 +$790,699 $0.43 16
2024 Q2 391,517 $89,517 -$8,321 $0.23 11
2024 Q1 371,232 $115,509 -$1,994,451 $0.31 11
2023 Q4 4,883,338 $2,151,708 +$2,045,684 $0.44 17
2023 Q3 237,143 $235,867 -$50,263 $1.00 10
2023 Q2 284,444 $327,598 +$11,438 $1.16 9
2023 Q1 271,491 $279,385 -$133,640 $1.03 8
2022 Q4 426,146 $262,014 -$39,908 $0.61 9
2022 Q3 480,663 $527,000 +$2,168 $1.10 6
2022 Q2 294,297 $1,235,000 -$433,172 $4.20 10
2022 Q1 375,986 $2,896,000 -$805,894 $7.86 10
2021 Q4 475,552 $4,007,000 +$165,915 $8.43 10
2021 Q3 539,906 $5,029,362 +$81,288 $11.33 14
2021 Q2 536,161 $4,344,316 +$396,634 $9.87 12
2021 Q1 467,061 $4,601,637 -$368,945 $12.39 12
2020 Q4 529,082 $3,747,276 +$1,082,695 $8.64 12
2020 Q3 442,094 $2,314,216 +$887,634 $6.75 10
2020 Q2 309,803 $723,108 +$170,070 $3.35 6
2020 Q1 260,799 $472,093 +$31,229 $2.90 6
2019 Q4 249,972 $670,139 -$8,525 $4.34 7
2019 Q3 253,418 $568,120 +$72,875 $3.75 7
2019 Q2 227,122 $324,083 +$51,992 $2.42 7
2019 Q1 205,065 $365,107 -$27,520 $3.34 5
2018 Q4 216,716 $293,078 -$12,948 $2.39 6
2018 Q3 220,931 $400,102 +$60,526 $3.24 8
2018 Q2 110,632 $1,746,095 +$33,415 $2.97 7
2018 Q1 94,669 $531,180 +$56,759 $5.61 6
2017 Q4 84,629 $269,000 +$269,000 $3.19 4